Total Payments
$360,587
2024 Payments
$105,225
Companies
52
Transactions
1,076
Medicare Patients
4,859
Medicare Billing
$639,126
Payment Breakdown by Category
Other$323,944 (89.8%)
Food & Beverage$19,625 (5.4%)
Travel$16,066 (4.5%)
Consulting$825.00 (0.2%)
Education$128.06 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $320,444 | 121 | 88.9% |
| Food and Beverage | $19,625 | 826 | 5.4% |
| Travel and Lodging | $16,066 | 121 | 4.5% |
| Honoraria | $2,500 | 1 | 0.7% |
| Grant | $1,000 | 1 | 0.3% |
| Consulting Fee | $825.00 | 3 | 0.2% |
| Education | $128.06 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $323,908 | 502 | $0 (2024) |
| PFIZER INC. | $16,722 | 54 | $0 (2023) |
| Advanced Respiratory, Inc | $3,589 | 19 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $2,330 | 4 | $0 (2018) |
| Grifols Shared Services North America, Inc. | $1,640 | 1 | $0 (2023) |
| GENZYME CORPORATION | $1,628 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,599 | 86 | $0 (2024) |
| Genentech, Inc. | $1,000 | 1 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $846.62 | 44 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $706.59 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $105,225 | 196 | GlaxoSmithKline, LLC. ($101,937) |
| 2023 | $107,820 | 189 | GlaxoSmithKline, LLC. ($104,405) |
| 2022 | $56,199 | 148 | GlaxoSmithKline, LLC. ($54,280) |
| 2021 | $46,814 | 135 | GlaxoSmithKline, LLC. ($45,462) |
| 2020 | $17,839 | 80 | GlaxoSmithKline, LLC. ($15,993) |
| 2019 | $8,329 | 97 | PFIZER INC. ($7,082) |
| 2018 | $10,594 | 106 | PFIZER INC. ($5,488) |
| 2017 | $7,767 | 125 | PFIZER INC. ($4,124) |
All Payment Transactions
1,076 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: Immunology | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Airway Clearance Device | ||||||
| 12/13/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $31.37 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $19.43 | General |
| Category: HFCWO | ||||||
| 11/19/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $155.67 | General |
| Category: VTE | ||||||
| 11/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.81 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Airway Clearance Device | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Pulmonology | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Immunology | ||||||
| 10/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: Immunology | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,096 | 1,818 | $1.1M | $133,024 |
| 2022 | 23 | 1,186 | 2,272 | $1.5M | $173,004 |
| 2021 | 26 | 1,246 | 2,254 | $1.2M | $159,559 |
| 2020 | 26 | 1,331 | 2,287 | $597,012 | $173,539 |
Total Patients
4,859
Total Services
8,631
Medicare Billing
$639,126
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 177 | 392 | $281,456 | $35,539 | 12.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 90 | 197 | $302,198 | $32,707 | 10.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 130 | 217 | $108,500 | $13,080 | 12.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 135 | $93,555 | $12,729 | 13.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 43 | $59,727 | $5,490 | 9.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 17 | 153 | $33,507 | $5,482 | 16.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 16 | 146 | $57,086 | $5,220 | 9.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 66 | $31,218 | $4,250 | 13.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 29 | $27,492 | $2,953 | 10.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 88 | 97 | $26,857 | $2,805 | 10.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $21,630 | $2,658 | 12.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $20,097 | $2,469 | 12.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 53 | 55 | $22,029 | $2,183 | 9.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 52 | 54 | $20,502 | $2,135 | 10.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 69 | 70 | $13,174 | $1,392 | 10.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $7,104 | $1,048 | 14.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $1,404 | $354.12 | 25.2% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 16 | 16 | $2,528 | $277.44 | 11.0% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 21 | 22 | $2,684 | $249.28 | 9.3% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2023 | 39 | 39 | $9.75 | $0.97 | 9.9% |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | Office | 2023 | 21 | 21 | $7.35 | $0.71 | 9.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 107 | 282 | $435,328 | $47,910 | 11.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 213 | 462 | $332,663 | $36,640 | 11.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 158 | 336 | $168,037 | $18,669 | 11.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 105 | $71,953 | $10,555 | 14.7% |
About Dr. Steven Davidoff, MD
Dr. Steven Davidoff, MD is a Pulmonary Disease healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114956554.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Davidoff, MD has received a total of $360,587 in payments from pharmaceutical and medical device companies, with $105,225 received in 2024. These payments were reported across 1,076 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($320,444).
As a Medicare-enrolled provider, Davidoff has provided services to 4,859 Medicare beneficiaries, totaling 8,631 services with total Medicare billing of $639,126. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine, Internal Medicine
- Location Plano, TX
- Active Since 06/30/2006
- Last Updated 10/17/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1114956554
Products in Payments
- AREXVY (Drug) $144,835
- TRELEGY ELLIPTA (Drug) $88,183
- ELIQUIS (Drug) $18,956
- ANORO ELLIPTA (Drug) $6,154
- Prolastin-C Liquid (Biological) $2,142
- DUPIXENT (Biological) $2,015
- ANORO (Drug) $804.84
- ACTHAR (Biological) $762.94
- BREO (Drug) $642.90
- Arikayce (Drug) $634.61
- FLOWTRIEVER CATHETER, S (Device) $634.53
- OFEV (Drug) $530.28
- NUCALA (Biological) $490.61
- SYMBICORT (Drug) $450.99
- Yupelri (Drug) $448.49
- DIFICID (Drug) $386.41
- BREZTRI (Drug) $377.83
- XARELTO (Drug) $376.61
- Hillrom - Vest System Model 105 Home Care (Device) $310.94
- SMARTVEST (Device) $266.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Plano
James Wilson, Md, MD
Pulmonary Disease — Payments: $56,034
Pulmonary Disease $56,034
Dr. Tayler Long, M.d, M.D
Pulmonary Disease — Payments: $15,358
Pulmonary Disease $15,358
Dr. Tameem Al-Aqtash, M.d, M.D
Pulmonary Disease — Payments: $9,379
Pulmonary Disease $9,379
Dr. Christopher Blewett, M.d, M.D
Pulmonary Disease — Payments: $7,690
Pulmonary Disease $7,690
Dr. Mythili Venkataraman, Md, MD
Pulmonary Disease — Payments: $7,119
Pulmonary Disease $7,119
Dr. John Hughes, M.d, M.D
Pulmonary Disease — Payments: $3,123
Pulmonary Disease $3,123